Rainmed Medical Limited (HKG:2297)

Rainmed Medical Statistics

Total Valuation

Rainmed Medical has a market cap or net worth of HKD 399.39 million. The enterprise value is 218.42 million.

Market Cap	399.39M
Enterprise Value	218.42M

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Rainmed Medical has 1.40 billion shares outstanding. The number of shares has increased by 0.55% in one year.

Current Share Class	1.40B
Shares Outstanding	1.40B
Shares Change (YoY)	+0.55%
Shares Change (QoQ)	+1.10%
Owned by Insiders (%)	47.84%
Owned by Institutions (%)	8.27%
Float	513.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.60
PB Ratio	0.89
P/TBV Ratio	0.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.92
EV / Sales	8.53
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.55

Financial Position

The company has a current ratio of 2.50, with a Debt / Equity ratio of 0.08.

Current Ratio	2.50
Quick Ratio	2.30
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	-0.26
Interest Coverage	-98.10

Financial Efficiency

Return on equity (ROE) is -23.91% and return on invested capital (ROIC) is -11.79%.

Return on Equity (ROE)	-23.91%
Return on Assets (ROA)	-10.21%
Return on Invested Capital (ROIC)	-11.79%
Return on Capital Employed (ROCE)	-22.14%
Weighted Average Cost of Capital (WACC)	7.46%
Revenue Per Employee	119,619
Profits Per Employee	-532,626
Employee Count	214
Asset Turnover	0.04
Inventory Turnover	1.19

Taxes

Income Tax	-38,352
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +98.63% in the last 52 weeks. The beta is 0.67, so Rainmed Medical's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	+98.63%
50-Day Moving Average	0.27
200-Day Moving Average	0.28
Relative Strength Index (RSI)	63.52
Average Volume (20 Days)	946,450

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Rainmed Medical had revenue of HKD 25.60 million and -113.98 million in losses. Loss per share was -0.10.

Revenue	25.60M
Gross Profit	11.32M
Operating Income	-98.89M
Pretax Income	-116.31M
Net Income	-113.98M
EBITDA	-87.38M
EBIT	-98.89M
Loss Per Share	-0.10

Balance Sheet

The company has 219.98 million in cash and 37.04 million in debt, with a net cash position of 182.94 million or 0.13 per share.

Cash & Cash Equivalents	219.98M
Total Debt	37.04M
Net Cash	182.94M
Net Cash Per Share	0.13
Equity (Book Value)	446.30M
Book Value Per Share	0.32
Working Capital	158.39M

Cash Flow

In the last 12 months, operating cash flow was -95.57 million and capital expenditures -44.97 million, giving a free cash flow of -140.54 million.

Operating Cash Flow	-95.57M
Capital Expenditures	-44.97M
Free Cash Flow	-140.54M
FCF Per Share	-0.10

Margins

Gross Margin	44.22%
Operating Margin	-386.32%
Pretax Margin	-454.35%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Rainmed Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.55%
Shareholder Yield	-0.55%
Earnings Yield	-28.54%
FCF Yield	-35.19%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Rainmed Medical has an Altman Z-Score of -5.98 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.98
Piotroski F-Score	1